Evolution of Oral Anticoagulant Therapy: How Advanced Formulations are Reshaping Cardiology Segments
The landscape of cardiovascular medicine has undergone a radical transformation with the introduction of Direct Oral Anticoagulants (DOACs). Among these, Factor Xa inhibitors have emerged as a cornerstone for preventing thromboembolic events. The primary use cases for these medications include the management of non-valvular atrial fibrillation and the treatment of deep vein thrombosis. Unlike...
0 Commentaires 0 Parts 246 Vue 0 Aperçu